Zovegalisib is an investigational new drug that is being evaluated by Relay Therapeutics for the treatment of HER2 negative breast cancer. It is a phosphatidylinositol 3 kinase alpha inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.